Literature DB >> 11240817

The experience of long-term hospital follow-up for women who have suffered early stage gynecological cancer: a qualitative interview study.

E.J. Bradley1, M.K. Pitts, C.W.E. Redman, E. Calvert.   

Abstract

Bradley EJ, Pitts MK, Redman CWE, Calvert E. The experience of long term hospital follow-up for women who have suffered early stage gynecological cancer: a qualitative interview study. The objective of this paper is to investigate the factors involved in the wish for continuing long-term follow-up for early stage gynecological cancer in the absence of obvious clinical benefit. This qualitative study is comprised of semistructured, individual interviews. Twelve women who had been treated for early stage (I-II) gynecological cancer (cervical, vulval, ovarian, endometrial) and had been attending regular follow-up appointments at the hospital clinic for a minimum of six months were interviewed for this study. The primary outcome measures were women's views on their follow-up needs. Women who continue to express a need for follow-up appointments years after the treatment of active disease are seeking to alleviate anxiety regarding possible recurrent illness. The main element of follow-up that alleviates this recurrence anxiety is medical reassurance, this is only judged to be worthwhile when given by a gynecological consultant. There is a difficulty with regarding the period of remission as a healthy state, both cultural "lay" beliefs and family support exacerbate this difficulty. Although family support is deemed important initially, it may actually serve to maintain "sickness" identity, perpetuating views of cancer remission as another stage of illness. We conclude that the processes involved in follow-up for cancers with a very low recurrence risk are complex. Follow-up information is perhaps medical, but women who have a continued need for follow-up in the absence of any clinical disease are attending for psychological purposes. Further research is needed to study possible interventions that could be introduced to help alleviate anxiety during the period of cancer recovery.

Entities:  

Year:  1999        PMID: 11240817     DOI: 10.1046/j.1525-1438.1999.99072.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  8 in total

Review 1.  Patients' and healthcare professionals' views of cancer follow-up: systematic review.

Authors:  Ruth A Lewis; Richard D Neal; Maggie Hendry; Barbara France; Nefyn H Williams; Daphne Russell; Dyfrig A Hughes; Ian Russell; Nicholas S A Stuart; David Weller; Clare Wilkinson
Journal:  Br J Gen Pract       Date:  2009-07       Impact factor: 5.386

Review 2.  Recurrent ovarian cancer: when and how to treat.

Authors:  Marcia Hall; Gordon Rustin
Journal:  Curr Oncol Rep       Date:  2011-12       Impact factor: 5.075

Review 3.  How Do We Follow Up Patients With Endometrial Cancer?

Authors:  Mette Moustgaard Jeppesen; Ole Mogensen; Dorte G Hansen; Stinne H Bergholdt; Pernille T Jensen
Journal:  Curr Oncol Rep       Date:  2019-05-15       Impact factor: 5.075

4.  GP-led melanoma follow-up: views and feelings of patient recipients.

Authors:  Peter Murchie; Elizabeth K Delaney; Neil C Campbell; Philip C Hannaford
Journal:  Support Care Cancer       Date:  2009-05-10       Impact factor: 3.603

5.  'We do need to keep some human touch'-Patient and clinician experiences of ovarian cancer follow-up and the potential for an electronic patient-reported outcome pathway: A qualitative interview study.

Authors:  Fiona Kennedy; Leanne Shearsmith; Marie Holmes; Rosemary Peacock; Oana C Lindner; Molly Megson; Galina Velikova
Journal:  Eur J Cancer Care (Engl)       Date:  2022-02-10       Impact factor: 2.328

Review 6.  Current approaches and challenges in managing and monitoring treatment response in ovarian cancer.

Authors:  Charlotte S Marcus; G Larry Maxwell; Kathleen M Darcy; Chad A Hamilton; William P McGuire
Journal:  J Cancer       Date:  2014-01-01       Impact factor: 4.207

7.  Patients' view of routine follow-up after breast cancer treatment.

Authors:  Vesna Bjelic-Radisic; Martha Dorfer; Karl Tamussino; Elfriede Greimel
Journal:  Wien Klin Wochenschr       Date:  2017-10-17       Impact factor: 1.704

8.  Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study.

Authors:  Fiona Kennedy; Leanne Shearsmith; Marie Holmes; Zoe Rogers; Rob Carter; Uschi Hofmann; Galina Velikova
Journal:  BMC Cancer       Date:  2022-07-02       Impact factor: 4.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.